Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Su_2016_Behav.Brain.Res_313_334

Reference

Title: Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling
Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J
Ref: Behavioural Brain Research, 313:334, 2016 : PubMed

        



Related information

Inhibitor | URB597,


Citations formats

Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J (2016)
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling
Behavioural Brain Research 313: 334-44

Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J (2016)
Behavioural Brain Research 313: 334-44



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer